Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme.

PROBLEM Virtually all women who have cervical cancer are infected with the human papillomavirus (HPV). Of the 275,000 women who die from cervical cancer every year, 88% live in developing countries. Two vaccines against the HPV have been approved. However, vaccine implementation in low-income countries tends to lag behind implementation in high-income countries by 15 to 20 years. APPROACH In ...

Implementing a school-based HPV vaccination programme.

BACKGROUND The Department of Health launched a national human papillomavirus immunisation programme for girls aged 12-13 years in September 2008. AIM To assess the feasibility and acceptability of implementing a school-based programme. METHOD HPV vaccination was offered over one academic year by two PCTs in 36 schools to 12-13-year-old girls, using different implementation plans. RESULTS ...

Factors affecting knowledge about human papillomavirus and its vaccination programme.

We have recently read an article in this Journal by Bowyer et al. that found ethnicity to be the only significant factor that predicted human papillomavirus (HPV) vaccine uptake amongst adolescent girls in England, UK. Shortly after the start of the vaccination programme, multivariate analysis of our cross-sectional study demonstrated that the level of knowledge regarding the HPV vaccination pr...

Vaccination against human papillomavirus

Human papillomavirus infection is common and causes different manifestations. This infection is a public health concern because it has been associated with genital tract malignant diseases among men and women. Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases.

Human papillomavirus vaccination.